A feasibility study to collect data in patients with haemophilia

Study identifier:D0960M00006

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A multi centre study with no treatment, designed to gain information about the haemophilia patient population

Medical condition

Hemophilia

Phase

Healthy volunteers

Study drug

Sex

Male

Actual Enrollment

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Dec 2008

Primary Completion Date: -

Study Completion Date: 01 Jun 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Malmö, Sweden

Location

Research Site

Stockholm, Sweden

Arms	Assigned Interventions
Other: 1 Laboratory variables	Other: Laboratory variables 1 visit

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1687&filename=CSR-D0960M00006.pdf
Download
CSR-D0960M00006.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study

800-236-9933

information.center@astrazeneca.com

Investigators

Principal Investigator

Erik Berntorp

Malmo University

A feasibility study to collect data in patients with haemophilia

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1687&filename=CSR-D0960M00006.pdf

CSR-D0960M00006.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator